Annual Working Capital
$4.04 M
-$765.40 K-15.93%
September 1, 2024
Summary
- As of February 12, 2025, DRUG annual working capital is $4.04 million, with the most recent change of -$765.40 thousand (-15.93%) on September 1, 2024.
- During the last 3 years, DRUG annual working capital has fallen by -$11.17 million (-73.44%).
- DRUG annual working capital is now -73.44% below its all-time high of $15.21 million, reached on September 30, 2021.
Performance
DRUG Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$4.04 M
-$404.30 K-9.10%
September 1, 2024
Summary
- As of February 12, 2025, DRUG quarterly working capital is $4.04 million, with the most recent change of -$404.30 thousand (-9.10%) on September 1, 2024.
- Over the past year, DRUG quarterly working capital has dropped by -$471.30 thousand (-10.45%).
- DRUG quarterly working capital is now -79.87% below its all-time high of $20.07 million, reached on March 31, 2021.
Performance
DRUG Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
DRUG Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.9% | -10.4% |
| 3 y3 years | -73.4% | -10.4% |
| 5 y5 years | +643.6% | -10.4% |
DRUG Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -73.4% | at low | -65.5% | at low |
| 5 y | 5-year | -73.4% | +643.6% | -79.9% | +643.6% |
| alltime | all time | -73.4% | +643.6% | -79.9% | +643.6% |
Bright Minds Biosciences Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $4.04 M(-15.9%) | $4.04 M(-9.1%) |
| Jun 2024 | - | $4.44 M(+6.2%) |
| Mar 2024 | - | $4.19 M(-7.2%) |
| Dec 2023 | - | $4.51 M(-6.1%) |
| Sep 2023 | $4.81 M(-37.3%) | $4.81 M(-16.8%) |
| Jun 2023 | - | $5.78 M(-12.0%) |
| Mar 2023 | - | $6.56 M(-18.3%) |
| Dec 2022 | - | $8.03 M(+4.9%) |
| Sep 2022 | $7.66 M | $7.66 M(+17.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $6.54 M(-24.1%) |
| Mar 2022 | - | $8.62 M(-26.4%) |
| Dec 2021 | - | $11.70 M(-23.1%) |
| Sep 2021 | $15.21 M(+2699.4%) | - |
| Sep 2021 | - | $15.21 M(-13.8%) |
| Jun 2021 | - | $17.65 M(-12.0%) |
| Mar 2021 | - | $20.07 M(+1126.3%) |
| Dec 2020 | - | $1.64 M(+201.2%) |
| Sep 2020 | $543.30 K | - |
| Sep 2020 | - | $543.30 K |
FAQ
- What is Bright Minds Biosciences annual working capital?
- What is the all time high annual working capital for Bright Minds Biosciences?
- What is Bright Minds Biosciences annual working capital year-on-year change?
- What is Bright Minds Biosciences quarterly working capital?
- What is the all time high quarterly working capital for Bright Minds Biosciences?
- What is Bright Minds Biosciences quarterly working capital year-on-year change?
What is Bright Minds Biosciences annual working capital?
The current annual working capital of DRUG is $4.04 M
What is the all time high annual working capital for Bright Minds Biosciences?
Bright Minds Biosciences all-time high annual working capital is $15.21 M
What is Bright Minds Biosciences annual working capital year-on-year change?
Over the past year, DRUG annual working capital has changed by -$765.40 K (-15.93%)
What is Bright Minds Biosciences quarterly working capital?
The current quarterly working capital of DRUG is $4.04 M
What is the all time high quarterly working capital for Bright Minds Biosciences?
Bright Minds Biosciences all-time high quarterly working capital is $20.07 M
What is Bright Minds Biosciences quarterly working capital year-on-year change?
Over the past year, DRUG quarterly working capital has changed by -$471.30 K (-10.45%)